Formestane

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Key facts

Formestane is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1993. DrugCentral lists 1 molecular target, including CYP19A1. Recorded indications include Carcinoma of female breast.

• Molecular targets: CYP19A1 (1 listed in DrugCentral).
• Indications: Carcinoma of female breast.
• ATC code: L02BG02 (Aromatase inhibitors).
• Molecular formula: C19H26O3; molecular weight 302.41 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Carcinoma of female breast

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Aromatase	CYP19A1	unknown	Ki 7.57

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1993-01-01	YEAR INTRODUCED	—	—

ATC classification

ATC code	Therapeutic hierarchy
L02BG02	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ENDOCRINE THERAPY › HORMONE ANTAGONISTS AND RELATED AGENTS › Aromatase inhibitors

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Formestane is on its molecule page.

• Molecular formula: C₁₉H₂₆O₃
• Molecular weight: 302.41 g/mol
• CAS number: —
• InChIKey: OSVMTWJCGUFAOD-KZQROQTASA-N
• PubChem CID: 11273

C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@]34C)[C@@H]1CCC2=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Formestane used for?

DrugCentral lists the following indications for Formestane: Carcinoma of female breast.

How does Formestane work?

Its molecular targets in DrugCentral include CYP19A1.

When was Formestane first approved?

Formestane was first approved by the YEAR INTRODUCED in 1993.

What is the chemical formula of Formestane?

Formestane has the molecular formula C19H26O3 and a molecular weight of 302.41 g/mol.

Sources

• DrugCentral drug card 1238 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL132530 — compound record and bioactivity
• PubChem CID 11273 — chemical identifiers
• DrugBank DB08905 — drug record
• FDA UNII PUB9T8T355 — substance identity
• UniProt P11511 (CYP19A1) — target protein

How this page is built: methodology · editorial policy & corrections.